Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.21.4
Stockholders' Equity (Tables)
12 Months Ended
Sep. 30, 2021
Stockholders' Equity  
Schedule of warrants issued and outstanding

Below is a summary of the Company’s issued and outstanding warrants as of September 30, 2021:

Expiration date

    

Exercise Price

    

Warrants Outstanding

December 13, 2021

$

55.00

20,627

April 10, 2022

20.00

695,312

July 6, 2023

 

8.73

 

105,000

September 20, 2024

6.50

75,000

 

895,939

    

    

    

Weighted

Weighted

Average

Average

Remaining 

Exercise

Contractual Life

Warrants

Price

(in years)

Outstanding as of September 30, 2019

 

728,439

$

20.99

 

Issued

105,000

8.73

Expired

(12,500)

20.00

Outstanding as of September 30, 2020

820,939

19.44

Issued

75,000

6.50

Outstanding as of September 30, 2021

895,939

18.35

0.9

Exercisable as of September 30, 2021

 

820,939

19.44

 

0.9

Schedule of key assumptions used to estimate the fair value of the advisory warrants granted

    

As of September 30,

 

2021

    

2020

 

Remaining contractual term (years)

 

3.0

 

3.0

Common stock price volatility

 

83.9

%  

86.4

%

Risk-free interest rate

 

0.5

%  

0.2

%

Expected dividend yield